PI
ANGO icon

PEAK6 Investments’s AngioDynamics ANGO Stock Holding History

PEAK6 Investments’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,700
Closed -$461K – 5085
2021
Q1 		$461K Buy
19,700
+15,500
+369% +$313K ﹤0.01% 3291
2020
Q4 		$64K Buy
4,200
+100
+2% +$1.27K ﹤0.01% 4161
2020
Q3 		$49K Hold
4,100
– – ﹤0.01% 4013
2020
Q2 		$42K Buy
+4,100
New +$42.3K ﹤0.01% 4055
2019
Q1 		– Sell
-4,300
Closed -$87K – 3772
2018
Q4 		$87K Sell
4,300
-7,200
-63% -$149K ﹤0.01% 3451
2018
Q3 		$250K Buy
+11,500
New +$255K ﹤0.01% 3085

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Investments's ANGO Position: Q3 2021 in Review

PEAK6 Investments sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 68 shares — an estimated $2K sold.

PEAK6 Investments first reported a position in ANGO in Q3 2018 and held it in 5 quarters. The position peaked at $157K in Q4 2018. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • PEAK6 Investments reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
  • PEAK6 Investments sold 68 AngioDynamics shares in Q3 2021, an estimated $2K.
  • PEAK6 Investments first reported a position in AngioDynamics in Q3 2018 and held it in 5 quarters.
  • PEAK6 Investments's AngioDynamics position peaked at $157K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on PEAK6 Investments's 13F filing for Q3 2021, filed 12 Nov 2021.